NCT05562479View on ClinicalTrials.gov

Effect of Sars-cov-2 on Donor Oocyte Quality and Quantity, a Multicenter Retrospective Study.

CompletedOBSERVATIONAL
Enrollment

428

Participants

Timeline

Start Date

December 12, 2021

Primary Completion Date

July 15, 2022

Study Completion Date

September 18, 2022

Conditions
Ovarian ReserveSARS-CoV-2 InfectionBlastocyst
Interventions
BIOLOGICAL

Sars Cov 2 infection

Donors recovered from Sars Cov 2 Infection

BIOLOGICAL

Sars Cov 2 vaccination

Egg Donors vaccinated

Trial Locations (1)

Unknown

Novafem, Bogotá

Sponsors

Lead Sponsor

Novafem
All Listed Sponsors
lead

Novafem

OTHER

NCT05562479 - Effect of Sars-cov-2 on Donor Oocyte Quality and Quantity, a Multicenter Retrospective Study. | Biotech Hunter | Biotech Hunter